Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Cobb

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature|September 23, 1998
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gammaR T Nolte, G B Wisely, S Westin, et al.
Journal of Medicinal Chemistry|February 2, 1996
The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinedionesT M Willson, J E Cobb, D J Cowan, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature|September 23, 1998
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gammaR T Nolte, G B Wisely, S Westin, et al.
Journal of Medicinal Chemistry|February 2, 1996
The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinedionesT M Willson, J E Cobb, D J Cowan, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Pageof 2